Biggest News Aggregation in the World
📰 Breaking News

Page 1973 - Breaking News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Breaking. Real-time updates on events, politics, business and more.

Bristol Myers Squibb: Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus

Deucravacitinib showed statistically significant efficacy at primary endpoint of Systemic Lupus Erythematosus (SLE) Responder Index-4 (SRI(4)) responses versus placebo at Week 32 Secondary endpoints
South Australia Jonathan Sadeh Bristol Myers Squibb Ericf Morand Monash University Bristol Myers Squibb Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science